| ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 36
Access to Research Data in the 21st Century: An Ongoing Dialogue Among Interested Parties - Report of a Workshop
Appendix B Agenda
Seeking Access to Research Data in the 21st Century: An Ongoing Dialogue Among Interested Parties Science, Technology, and Law Program The National Academies Washington, D.C.
March 12, 2001
Auditorium
7:30
Continental Breakfast – Great Hall
8:00
Welcome
Don Kennedy, President Emeritus, Stanford University, and Editor-in Chief, Science Cochair, Science, Technology, and Law Program
8:20
Historical Perspective: Overview of Forsham v. Harris, the Shelby Amendment, Public Comment, OMB revisions to Circular A-110 OMB.
Frederick R. Anderson, Jr., Partner, Cadwalader, Wickersham & Taft
OCR for page 37
Access to Research Data in the 21st Century: An Ongoing Dialogue Among Interested Parties - Report of a Workshop
8:45
Question and Answer
9:00
Panel 1: Understanding the scientific process: What is the universe of data, what is publication, how are scientific data validated?
a. The scientific process from experimental design to data collection and analysis to publication/peer review. What is meta-analysis? What are its strengths and limitations?
b. The Harvard Six Cities Study. What was the experimental design? What data were collected? What protections of confidentiality were promised to study participants?
Moderator
David Korn, Senior Vice President for Biomedical and Health Sciences Research, Association of American Medical Colleges
Panelists:
Steven Goodman, Associate Professor, Department of Biostatistics, Johns Hopkins University
Douglas W. Dockery, Professor of Environmental Epidemiology and Professor of Medicine, Department of Environmental Health, Harvard Medical School
10:10
Question and Answer
10:30
Break – Great Hall
10:45
Panel 2: Public accessibility to research data used in rule making. What is the problem? (Who should have access, and by what process, to data the agency relies on or proposes to rely on, and to data submitted by public and private entities seeking agency consideration? What are the countervailing concerns about permitting access to such data, and what protections must be in place to protect trade secrets, individual privacy, etc.?)
Moderator
Alan Morrison, Director, Public Citizen Litigation Group
Panelists
William L. Kovacs, Vice President, Environment, Technology, and Regulatory Affairs, U.S. Chamber of Commerce
Bruce Alberts, President, National Academy of Sciences
William H. Farland, Acting Deputy Assistant Administrator for Science, Office of Research and Development, U.S. Environmental Protection Agency
OCR for page 38
Access to Research Data in the 21st Century: An Ongoing Dialogue Among Interested Parties - Report of a Workshop
Wendy Baldwin, Deputy Director for Extramural Research, National Institutes of Health
David G. Hawkins, Director, Air and Energy Program, Natural Resources Defense Council
Jim J. Tozzi, Member, Board of Advisors, Center for Regulatory Effectiveness
12:30
Question and Answer
1:00
Lunch – The Great Hall
Protective Orders -The Impact of Secrecy on Public Health and Safety Decisions
The Honorable Jack B. Weinstein, Senior Judge, United States District Court for the Eastern District of New York
2:30
Panel 3: Alternative approaches to permitting public access to data used in regulatory/policy decisions
Moderator
Joel E. Cohen, Abby Rockefeller Mauze Professor and Head, Laboratory of Populations, The Rockefeller University and Professor of Populations, Columbia University
Panelists
Robert O’Keefe, Vice President, Health Effects Institute
E. William Colglazier, Executive Officer, National Research Council
Barry S. Kramer, Director, Office of Medical Applications of Research, National Institutes of Health
Kenneth W. Harris, Acting Director, Research Data Center, National Center for Health Statistics
3:40
Question and Answer
4:00
Closing
Richard A. Merrill, Daniel Caplin Professor of Law and Sullivan and Cromwell Research Professor of Law University of Virginia Law School Cochair, Science, Technology, and Law Program
4:30
Reception – The Great Hall
Representative terms from entire chapter:
ongoing dialogue
